ArdorComm Media Group

Thursday, October 8, 2026 6:50 PM

AI in healthcare

Healthcare’s Next Revolution: From Artificial Intelligence to Personalised Care

Healthcare is entering an era where the most important medical breakthrough may not be a new drug or device, but the ability to understand each patient in greater depth. Artificial intelligence can analyse vast amounts of medical data, precision medicine can help match treatments to individual biological profiles, and digital health can bring care closer to where people live and work.  Together, these technologies are beginning to shift healthcare from a largely reactive system to one that can anticipate risks, personalise interventions and support patients beyond the hospital. As these capabilities mature, the healthcare landscape of 2030 could look fundamentally different from the one we know today. From Reactive Healthcare to Predictive Care For decades, much of healthcare has been reactive. A patient develops symptoms, seeks medical attention, undergoes tests and then receives treatment. Advances in data science are gradually changing this sequence. AI systems can analyse large and complex datasets, identify patterns and support disease detection, diagnosis and treatment decisions. Regulatory agencies such as the US Food and Drug Administration already recognise the growing role of AI-enabled medical devices in clinical care.  Imagine a healthcare system where a combination of medical history, laboratory results, imaging, lifestyle information and continuously collected health data can help identify a patient’s changing risk before a serious condition becomes apparent. This does not mean AI will independently diagnose every patient. Rather, its most valuable role may be as an additional layer of intelligence supporting healthcare professionals. The doctor will still need to understand the patient. AI can help process the enormous amount of information surrounding that patient. AI Becomes a Clinical Assistant, Not a Replacement for Doctors The most realistic future of AI in healthcare is not a world without doctors. It is a world in which doctors have better tools. AI can assist with analysing medical images, identifying patterns in clinical data, summarising patient records, supporting clinical decision-making and reducing some administrative workloads. In research and pharmaceutical development, AI can also help researchers work through large datasets and identify potential avenues for investigation. But healthcare is fundamentally different from many other industries. A medical decision can have consequences that cannot simply be reversed. That makes accuracy, validation and human oversight essential. The FDA notes that AI-enabled medical technologies require careful consideration throughout their lifecycle, while international guidance on good machine-learning practice emphasises safe, effective and high-quality development.  The future doctor may therefore work alongside an increasingly sophisticated digital assistant—one that can process information at a scale that humans cannot, while the physician remains responsible for clinical judgement, communication and the human side of care. The Rise of Precision Medicine Perhaps the most important change will be the gradual move away from the idea that one treatment should work equally well for everyone. Two patients can have the same diagnosis but respond very differently to the same medicine. Their genetics, environment, lifestyle, medical history and other biological characteristics can influence both disease risk and treatment response. Precision medicine attempts to account for these differences. Large research programmes are already demonstrating what becomes possible when different forms of health information are brought together. The US National Institutes of Health’s All of Us Research Program, for example, combines information including electronic health records, genomic data, physical measurements, surveys and wearable-device data to support research into more individualised approaches to prevention and treatment.  By 2030, the expansion of such datasets could help medicine become increasingly targeted. Instead of asking simply, “What treatment is normally used for this disease?”, clinicians may increasingly ask, “What treatment is most appropriate for this particular patient?” That is a profound change in the philosophy of healthcare. Digital Health Will Make Care More Continuous Healthcare is also moving beyond the hospital and clinic. Smartwatches, connected medical devices, remote monitoring systems and digital health platforms are creating new ways to collect information outside traditional healthcare settings. For patients with chronic conditions, this could mean that important health indicators are monitored between appointments rather than assessed only during occasional clinical visits. The result could be a more continuous relationship between patients and healthcare providers. A patient may no longer need to wait until the next appointment to discover that something has changed. A healthcare professional could potentially receive relevant information earlier and decide whether intervention is necessary. But digital health should not become an endless stream of notifications. The real objective is not to collect more data; it is to turn useful data into meaningful action. The Patient Will Become More Connected to the Healthcare System Another major shift could be the changing role of patients themselves. Digital platforms are already making it easier for people to access health records, communicate with healthcare providers, monitor certain health indicators and participate in their own care. Over time, patients may have a more complete picture of their health rather than receiving fragmented information from different doctors, hospitals and diagnostic centres. This could also encourage a shift from treatment-oriented healthcare towards prevention. Instead of focusing exclusively on managing disease after it appears, healthcare systems could increasingly use data to identify risk earlier and encourage interventions before a condition becomes more serious. The Data Challenge There is, however, a major obstacle behind almost every digital healthcare ambition: data. Healthcare data is highly sensitive. Medical records, genomic information, biometric measurements and information generated by wearable devices can reveal deeply personal details about an individual. The more healthcare becomes data-driven, the more important privacy, cybersecurity, consent and responsible data governance become. WHO has repeatedly stressed that AI in healthcare needs to be developed and deployed with safety, ethics, equity and appropriate governance at its core. It has also warned that poorly governed AI could deepen existing inequalities rather than reduce them.  This is particularly important for countries with significant differences in healthcare access. A sophisticated AI system is of limited value if the people who need healthcare most cannot access the digital infrastructure required to use it. The Risk of a Digital Divide The healthcare revolution must therefore address a

Healthcare’s Next Revolution: From Artificial Intelligence to Personalised Care Read More »

Healthcare 2030: How AI, Precision Medicine and Digital Health Will Transform Patient Care

Healthcare has always evolved alongside science. But the transformation taking place today is different in scale and speed. Artificial intelligence, precision medicine and digital health are no longer ideas confined to research laboratories or futuristic films. They are increasingly becoming part of how diseases are detected, treatments are planned and patients interact with healthcare systems. By 2030, the biggest change may not be that hospitals have become more technologically advanced. It may be that healthcare has become more personalised, predictive and connected. The question is no longer whether technology will enter healthcare. It is how responsibly it will be used—and whether patients, doctors and healthcare institutions will be ready for that change. From Treating Illness to Predicting Risk For generations, healthcare has largely operated on a reactive model: a person develops symptoms, visits a doctor, undergoes tests and receives treatment. Digital health could gradually shift this model towards prevention. Wearable devices can continuously collect information such as heart rate, sleep patterns, physical activity and, increasingly, other health indicators. Combined with electronic health records and AI systems, such data could help identify unusual patterns before they become obvious symptoms. Imagine a patient whose digital health profile gradually shows changes in sleep, heart rate and activity. Instead of waiting until that person arrives at a hospital with a serious complaint, an intelligent system could flag the pattern for medical review. The technology would not replace the doctor. It could give the doctor an earlier signal. That distinction is important. The future of healthcare is unlikely to be “AI versus doctors”. It is more likely to be doctors supported by better information. AI: The New Layer of Healthcare Artificial intelligence could become one of the most influential technologies in healthcare by 2030. AI systems are already being explored for medical imaging, clinical decision support, drug discovery, administrative work and patient engagement. Their potential lies partly in their ability to process enormous volumes of information much faster than humans can. For a radiologist, for example, AI could help identify patterns in medical images that deserve closer examination. For researchers, AI could help analyse biological data and accelerate the search for potential drug candidates. For hospitals, intelligent systems could help manage appointments, records and workflows. But healthcare is not simply another data-processing industry. A wrong recommendation can have consequences for a person’s life. That makes accuracy, transparency, privacy and accountability essential. By 2030, one of the most important questions may therefore not be “How powerful is the AI?” but “How safely is the AI being used?” Human oversight will remain critical, particularly in diagnosis and treatment decisions. The Rise of Precision Medicine Two patients can have the same disease and still respond very differently to the same treatment. This is where precision medicine could change the traditional approach to healthcare. Instead of relying primarily on broad categories such as age, symptoms or disease type, precision medicine seeks to understand a patient’s individual characteristics—including genetics, lifestyle, environment and other biological factors. Consider cancer treatment. A tumour that appears similar under conventional examination may have different molecular characteristics in different patients. Understanding those differences can help clinicians identify treatments that are more appropriate for a particular patient. By 2030, advances in genomics and data analytics could make this approach increasingly relevant across several areas of medicine. The long-term ambition is simple: move from a “one treatment fits many” approach towards treatment decisions that are increasingly tailored to the individual. However, access will be a major question. Precision medicine can be expensive and data-intensive. If advanced personalised healthcare remains concentrated in major cities and high-income settings, technological progress could widen existing healthcare inequalities rather than reduce them. Your Smartphone Could Become Part of Your Healthcare Journey The hospital of 2030 may not begin at the hospital. It could begin with a smartphone. Digital health is creating new ways for patients to communicate with healthcare providers, access medical records, monitor health conditions and receive reminders or follow-up care. Telemedicine has already demonstrated how geographical barriers can be reduced. Remote consultations, digital prescriptions and connected medical devices can potentially bring elements of healthcare closer to people’s homes. For countries such as India, this could be particularly significant. A patient living far from a specialist centre may not need to travel hundreds of kilometres for every follow-up consultation. A local healthcare worker could potentially collect relevant information digitally and connect with specialists elsewhere. Technology cannot eliminate the shortage of doctors or infrastructure overnight. But it can help healthcare systems use limited resources more efficiently. The Data Dilemma There is, however, another side to this digital transformation. Healthcare’s future will depend heavily on data—and health data is among the most sensitive information a person can share. Who owns the data generated by a wearable device? Who can access an electronic health record? How long should medical data be stored? Can an individual’s health information be used to train an AI system? What happens if sensitive information is leaked? These are not merely technology questions. They are questions of trust. A healthcare system cannot become truly digital if patients are afraid to use it. By 2030, strong data governance, cybersecurity, informed consent and transparent policies will need to develop alongside technological innovation. The more connected healthcare becomes, the more important trust will become. Doctors Will Still Matter—Perhaps More Than Ever One common fear surrounding healthcare AI is that machines could replace doctors. The more realistic scenario is different. AI may automate some repetitive tasks, identify patterns and assist with decision-making. But medicine involves more than analysing information. Doctors listen to patients, understand context, explain difficult choices and make decisions when evidence is incomplete. A machine may recognise a pattern in a scan. A doctor must still explain what that finding means for a particular person. Technology can process data. Healthcare professionals provide context, judgement and human connection. The healthcare professional of 2030 may therefore need a different skill set: not simply knowing medicine, but knowing how to work effectively with AI and

Healthcare 2030: How AI, Precision Medicine and Digital Health Will Transform Patient Care Read More »

IIT Dhanbad Professor Unveils AI-VR Device ‘EchoPulse’ for Rapid Heart Disease Detection

A breakthrough innovation from IIT (ISM) Dhanbad promises to transform cardiac diagnostics. Professor ACS Rao from the Department of Computer Science and Engineering has developed EchoPulse—a cutting-edge device that combines Artificial Intelligence and Virtual Reality to enable faster and more accurate heart disease diagnosis. EchoPulse is designed to analyse heart scan images intelligently, identifying patterns without heavy reliance on time-consuming manual processes. Unlike conventional AI systems, it reduces dependency on large volumes of pre-labelled medical data, making it more efficient and scalable. A standout feature of the device is its VR capability, which allows doctors to visualise heart activity in an interactive 3D environment. This immersive view helps medical professionals better understand complex cardiac conditions and improves clinical decision-making. The system also incorporates explainable AI, ensuring transparency in how results are generated. Instead of functioning as a “black box,” EchoPulse enables doctors to interpret the reasoning behind its findings, building trust and usability in real-world healthcare settings. Additionally, the device can estimate key clinical parameters, such as the heart’s blood-pumping efficiency, supporting early diagnosis and effective treatment planning. According to Prof. Rao, EchoPulse has the potential to make advanced cardiac diagnostics more accessible, particularly in regions with limited healthcare infrastructure. The project has received funding of approximately ₹47 lakh from the Anusandhan National Research Foundation. Source: PTI

IIT Dhanbad Professor Unveils AI-VR Device ‘EchoPulse’ for Rapid Heart Disease Detection Read More »

IISc’s Centre for Brain Research Unveils ₹2 Crore AI Challenge for Early Detection of Cognitive Decline

The Indian Institute of Science (IISc), through its Centre for Brain Research (CBR), has announced a ₹2 crore AI-driven challenge aimed at enabling early detection of cognitive decline. The initiative invites researchers and innovators from Indian institutions to design predictive models using extensive brain-aging datasets, including longitudinal data collected within India. The six-month competition is being conducted in collaboration with the Alzheimer’s Disease Data Initiative and Microsoft Research India. According to K.V.S. Hari, Director of CBR, early identification of cognitive decline can pave the way for cost-effective and scalable interventions, especially benefiting the elderly population. He emphasized that artificial intelligence has the potential to uncover deeper insights into brain health and accelerate advancements in this field. The challenge focuses on developing AI models capable of predicting mild cognitive impairment and dementia, while also enhancing the understanding of disease progression. Participants will work with multi-modal datasets to build robust, scalable solutions addressing critical brain-aging concerns. Senapathy Kris Gopalakrishnan highlighted that leveraging AI in brain research can significantly improve prediction accuracy, research capabilities, and treatment outcomes, ultimately addressing the growing burden of dementia. Applications for the challenge are open from April 20 to May 20. Entries will be evaluated by an expert panel, and selected winners will receive a combination of cash prizes and research grants totaling ₹2 crore to further develop their innovations. Source: The Hindu  

IISc’s Centre for Brain Research Unveils ₹2 Crore AI Challenge for Early Detection of Cognitive Decline Read More »

India, France Inaugurate Indo-French Centre for AI in Health at AIIMS Delhi

In a major step to deepen bilateral cooperation in healthcare and emerging technologies, Union Health Minister JP Nadda and French President Emmanuel Macron jointly inaugurated the Indo-French Centre for AI in Health (IFCAIH) at All India Institute of Medical Sciences (AIIMS), New Delhi. The newly launched centre is envisioned as a pioneering platform to accelerate AI-driven research, strengthen medical education, and promote clinical innovation. According to official sources, the IFCAIH aims to tackle complex healthcare challenges while fostering interdisciplinary collaboration between Indian and French institutions. Addressing the gathering, President Macron underlined the importance of developing sovereign AI capabilities. He stressed that India and France must build their own computing capacity and skilled talent to create trusted AI systems, rather than relying entirely on technologies developed elsewhere. He added that artificial intelligence must serve humanity, with strong safeguards for children, algorithmic transparency to reduce bias, and a commitment to preserving linguistic and cultural diversity. The launch of the centre coincided with the Rencontres Universitaires et Scientifiques de Haut Niveau (RUSH) 2026, a high-level academic and scientific forum organised at AIIMS on February 18 and 19 by the French Embassy. A key session titled “Indo-French Forum: AI in Brain Health and Global Healthcare” brought together scientists, clinicians, policymakers, and academic leaders from both nations to explore collaborative solutions in global health. The IFCAIH has been established under a joint Memorandum of Understanding between AIIMS, Sorbonne University, and Paris Brain Institute, with additional collaboration from Indian Institute of Technology Delhi and other leading French institutions. The initiative builds upon ongoing India-France cooperation in priority areas such as digital health, antimicrobial resistance, human resources for health, and the responsible use of health data. As part of the RUSH 2026 programme, President Macron engaged with young Indian innovators, including Priyanka Das Rajkakati and Manan Suri, during an interactive session moderated by Clara Chappaz, spotlighting youth-led innovation and cross-border AI collaboration. The event also featured a special segment at the Jawaharlal Auditorium highlighting major scientific and academic cooperation milestones between France and India. Moderated by Prof. Vijay Raghavan and Dr. Thierry Coulhon, Chairmen of RUSH, the session showcased expanding partnerships in higher education, research, and innovation. Union Minister JP Nadda reaffirmed India’s commitment to strengthening AI-enabled healthcare collaboration with France, noting that the new centre will serve as a catalyst for innovation, capacity building, and global knowledge exchange. President Macron later posted on X that France and India are mobilising AI for research, training, and innovation for the common good, reinforcing the shared vision of ethical, inclusive, and globally beneficial AI in healthcare. Source: ANI

India, France Inaugurate Indo-French Centre for AI in Health at AIIMS Delhi Read More »

IIT Delhi Introduces Executive Programme in Healthcare Entrepreneurship and Management

The Indian Institute of Technology (IIT) Delhi has rolled out a new executive programme focused on healthcare entrepreneurship and management, aimed at nurturing professionals who can drive innovation in India’s rapidly evolving healthcare sector. The programme will be conducted under IIT Delhi’s Continuing Education Programme (CEP), a statutory body authorised to run certificate courses and award credentials. According to IIT Delhi, the initiative is designed to equip participants with the skills and mindset required to navigate and shape the future of healthcare innovation. Applicants must possess a bachelor’s degree, while prior professional experience or exposure to projects in related domains will be considered an added advantage. The five-month programme will be delivered through live online classes held on weekends, complemented by dedicated hours for project work. The institute noted that India’s healthcare ecosystem is witnessing transformative changes, driven by the rise of digital health solutions, medical devices, artificial intelligence–enabled diagnostics, wearable technologies and a stronger focus on patient-centric care. However, persistent challenges such as fragmented service delivery, regulatory hurdles, limited commercialisation avenues and the demand for cross-disciplinary leadership continue to affect the sector. Against this backdrop, the executive programme aims to provide a comprehensive understanding of the entire healthcare innovation lifecycle. Through interactive online sessions and guided projects, participants will learn how to identify healthcare challenges and translate them into viable, market-ready solutions using design thinking, prototyping, testing and sound commercial strategies. The programme will be anchored by IIT Delhi’s Centre for Biomedical Engineering and supported by clinical expertise from specialists at AIIMS Delhi. Faculty members including Dr Arnab Chanda and Dr Biswarup Mukherjee will lead the sessions, integrating engineering, clinical practice, management and entrepreneurship to foster practical and scalable healthcare innovations. A major feature of the course is its strong emphasis on project-based learning. Participants will work on real-world healthcare problems, developing deployable prototypes with the help of structured mentoring, peer collaboration and continuous expert feedback. On successful completion, learners will receive an e-certificate from CEP, IIT Delhi, and gain access to a network of IIT Delhi faculty, AIIMS clinicians and industry professionals, enhancing both learning outcomes and professional opportunities. Source: Indian Express

IIT Delhi Introduces Executive Programme in Healthcare Entrepreneurship and Management Read More »

NMC Clears Path for For-Profit Firms to Establish Medical Colleges

The National Medical Commission (NMC) has officially revised its regulations to allow for-profit companies to set up medical colleges in India, marking a significant shift from the earlier framework that restricted such institutions to non-profit Section 8 companies. Announcing the change, NMC Chairman Abhijat Chandrakant Sheth said the decision was taken at a recent board meeting and removes the clause that limited eligibility to non-profit entities. The revised policy now enables both non-profit and for-profit organisations to establish medical colleges, particularly under the Public-Private Partnership (PPP) model. Speaking at a press briefing at Dr NTR University of Health Sciences in Vijayawada, Sheth said the move is intended to improve the utilisation of resources in medical education by encouraging collaboration between public authorities and private players. He added that PPP-based medical institutions are already functioning effectively in states such as Gujarat. Sheth noted that while the PPP model will be implemented at the discretion of state governments, hospitals operating under such arrangements will remain under state oversight. As a result, patients will continue to receive treatment either free of cost or at subsidised rates. To maintain academic and institutional standards, the NMC has developed its own accreditation framework and Standard Operating Procedures (SOPs). The commission’s broader objective, Sheth said, is to expand access to quality medical education for the general population while aligning with global benchmarks. Highlighting ongoing reforms, he said the NMC is continuously updating its policies to reflect evolving needs in healthcare education. As part of these efforts, clinical research has been made mandatory, with increased emphasis on artificial intelligence, digital healthcare, and emerging medical technologies to future-proof medical training in India. Source: PTI

NMC Clears Path for For-Profit Firms to Establish Medical Colleges Read More »

AI Tool Boosts India’s Disease Surveillance, Generates Over 5,000 Alerts: Study

An artificial intelligence–powered surveillance system deployed by the National Centre for Disease Control (NCDC) has significantly strengthened India’s ability to track infectious disease outbreaks, generating more than 5,000 real-time alerts for health authorities since 2022, according to a new pre-print study. Developed by WadhwaniAI, the Health Sentinel platform has automated the labor-intensive task of scanning news reports for unusual health events. The system reportedly reduced manual workload by 98%, enabling faster outbreak detection and quicker public health action. The findings are currently under review and not yet peer-reviewed. Under India’s Integrated Disease Surveillance Programme (IDSP), media scanning and verification has long relied on manual review of print, television and online news. Health Sentinel upgrades this process by screening articles daily across 13 languages, applying AI models to highlight potential threats that are later reviewed by epidemiologists. According to the study, the platform has processed over 300 million news articles since April 2022, identifying 95,000+ unique health-related events, of which around 3,500 were shortlisted by NCDC experts as possible outbreaks. Researchers also estimate that the AI-enabled system triggered more than 5,000 actionable alerts between April 2022 and April 2025. Parag Govil, National Program Lead for Global Health Security at WadhwaniAI, said the tool preserves human oversight while eliminating the time-consuming manual scanning traditionally required. Epidemiologists validate flagged events before disseminating them to state and district authorities. The research team noted a 150% surge in published health events captured since adopting AI-assisted surveillance, compared to earlier years of fully manual analysis. In 2024 alone, 96% of reported events were identified through the AI system, with only 4% coming from manual review. Globally, event-based surveillance techniques that incorporate online media or social media sources are increasingly used to complement traditional “passive reporting” from healthcare providers. The volume of daily online content, however, has made manual screening impractical, making automated systems essential. The article also references other Indian studies highlighting the value of enhanced surveillance. A pilot conducted in six private hospitals in Kasaragod, Kerala, used an algorithm to analyse cases of acute febrile illness (AFI). The system detected 88 clusters, with several verified as outbreaks—including dengue and COVID-19—demonstrating the benefits of early, data-driven detection. International research supports similar conclusions. A 2020 review in the Journal of Biomedical Informatics found that machine learning–based analysis of social media posts, especially on Twitter, improved disease trend prediction. Another study, published in 2017 in the American Journal of Tropical Medicine and Hygiene, showed that mining news articles can help fill gaps when official national case data is delayed. Overall, the findings underscore the growing importance of AI-driven surveillance systems in strengthening public health response capabilities and improving global health security. Source: PTI

AI Tool Boosts India’s Disease Surveillance, Generates Over 5,000 Alerts: Study Read More »

WHO Urges Boost in TB Research and Innovation to Tackle High Burden in South-East Asia

The World Health Organization (WHO) has issued an urgent call to enhance research, innovation, and regional cooperation to eliminate tuberculosis (TB) in the South-East Asia region — a region that continues to carry nearly half of the global TB burden. Speaking at the launch of a three-day virtual workshop focused on advancing TB research and innovation, Dr. Catharina Boehme, Officer-in-Charge for WHO South-East Asia, emphasized that in 2023 alone, the region saw nearly 5 million new TB cases and around 600,000 related deaths. The workshop brings together national TB programme leaders, scientists, civil society members, and global partners to push forward efforts aligned with the WHO’s End TB Strategy. The Need for Urgency and Collaboration Dr. Boehme highlighted that ending TB demands the rapid adoption of new tools, diagnostics, and treatments — and, more importantly, equitable and timely access to these innovations. “Collaboration is key to scaling up impact and ensuring that no one is left behind,” she stated. Despite a post-COVID-19 rebound in TB case detection in 2023, current progress is falling short of the End TB Strategy’s 2030 goals: a 90% drop in TB-related deaths and an 80% decline in incidence compared to 2015. Alarmingly, TB has returned as the world’s leading cause of death from a single infectious disease, with its effects disproportionately hitting the poorest and most vulnerable communities. In South-East Asia, between 30% and 80% of TB-affected households experience catastrophic healthcare expenses, pointing to the urgent need for inclusive, people-first approaches and stronger social protection systems. Signs of Progress Amidst Challenges Still, there are signs of advancement. In 2023, the region recorded 3.8 million new or relapsed TB cases, with an 89% treatment success rate among those who began treatment in 2022. The number of undiagnosed cases was significantly reduced — down to 22% from 44% in 2020. Countries are increasingly adopting technology-driven solutions such as artificial intelligence for detecting TB, digital adherence tools to monitor treatment, and direct benefit transfers to ease patients’ financial burdens. These innovations are being powered by strong political will and national commitment. Several countries have also expanded research efforts. Bangladesh has concluded a national patient cost survey, while India’s RATIONS study provided valuable insights on the role of nutrition in TB prevention and recovery. Nepal’s “TB-Free Pallika” initiative and Myanmar’s multisectoral coordination model are examples of community-led innovations that prioritize vulnerable populations. According to WHO, over 3,000 TB-related research papers were published by South-East Asian countries in the past six years, with 60% being original research. However, the challenge lies in transforming these findings into action, as knowledge gaps and lack of collaborative platforms hinder broader impact. Strengthening Regional and Global Coordination The workshop will also focus on building stronger South-South collaboration, vaccine readiness, use of digital tools for patient care, and tackling vaccine hesitancy. Discussions will revolve around aligning regulatory frameworks, improving knowledge-sharing platforms, and setting research priorities that address underlying drivers of TB — such as malnutrition and climate-related risks. Dr. Boehme noted the growing threat posed by drug-resistant TB and emphasized the importance of ensuring that scientific progress benefits everyone equally. “Access to new vaccines, medicines, and diagnostics must be equitable. Reaching underserved communities through proactive case-finding and offering socio-economic support is essential in mitigating the financial toll of TB,” she concluded. Source: PTI Photo Credit: Getty Images

WHO Urges Boost in TB Research and Innovation to Tackle High Burden in South-East Asia Read More »

JSS AHER Collaborates with Google Research to Advance AI-Powered Healthcare

In a significant leap for India’s medical research landscape, JSS Academy of Higher Education and Research (JSS AHER), Mysuru, has joined forces with Google Research on a pioneering artificial intelligence (AI) healthcare initiative. The outcomes of this collaboration were recently published in two prestigious papers in the journal Nature, underscoring the project’s global relevance and impact. At the heart of the research lies the development of the Articulate Medical Intelligence Explorer (AMIE) — an innovative AI system designed by Google Research to improve diagnostic precision and enhance communication between doctors and patients. The studies assessed AMIE’s capabilities in comparison with trained primary care physicians, using standardized, text-based medical consultations across healthcare systems in India, the UK, and Canada. Dr. B. Suresh, Pro-Chancellor of JSS AHER, expressed pride in the institution’s role in shaping the future of healthcare, stating, “We are at the cutting edge of digital health and AI innovation. In line with these advances, we have also revised our pharmacy curriculum to include AI, ensuring our graduates are equipped for the evolving landscape of medicine.” Echoing this vision, Vice-Chancellor Dr. H. Basavanagowdappa highlighted the institution’s commitment to fostering an innovation-centric academic environment. “This international collaboration enhances our academic standing and gives our students and faculty the opportunity to tackle real-world healthcare issues. Our mission is to develop forward-looking solutions for global health,” he said. With this partnership, JSS AHER cements its position as a leading hub for digital health research, merging academic excellence with cutting-edge technological collaboration. Source: Economic Times  

JSS AHER Collaborates with Google Research to Advance AI-Powered Healthcare Read More »